Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novartis has reported net sales of $14.92bn for the fiscal second quarter ended 30 June 2011, an increase of 27%, compared to $11.72bn for the same period in 2010.
Subscribe to our email newsletter
For the second quarter of 2011, the company has generated net income of $2.73bn, compared to $2.44bn for the same period in the prior year.
Net sales were $28.94bn for the six months ended 30 June 2011, compared to $23.85bn for the same period in 2010.
Net income was $5.55bn for the six months of 2011, compared to $5.39bn for the same period in last year.
Novartis CEO Joseph Jimenez said they achieved sales growth of 19% in constant currencies and margin improvement of 0.4% points in US dollars.
"We further demonstrated the success of our R&D strategy with four major approvals and two filings in the second quarter," Jimenez said.